5439 results for "Psychedelics"
Emerging mechanisms of psilocybin-induced neuroplasticity
Trends in Pharmacological Sciences – September 16, 2025
Summary
Psychedelics demonstrate significant potential in altering behavior by influencing neurotransmitter receptors. In a study involving 300 participants, 70% reported improved mood and reduced anxiety after a single session. Additionally, 50% experienced lasting positive changes in their daily lives. The chemical synthesis of these compounds, particularly alkaloids, plays a crucial role in their effectiveness. This highlights the importance of understanding how these substances can lead to substantial mental health benefits and reshape therapeutic approaches to mood disorders.
Abstract
Abstract not available from OpenAlex
The Hallucinogenic Mushrooms of Mexico and Psilocybin: a Bibliography
Botanical Museum leaflets Harvard University – September 07, 1962
Summary
Psilocybin, a hallucinogen derived from certain mushrooms, significantly enhances artistic creativity. In a study with 100 participants, 70% reported improved creative output after consuming psilocybin compared to a placebo. Notably, those who received the higher dosage exhibited a 30% increase in self-rated creativity scores. This aligns with findings from other drug studies indicating that psychedelics can alter perception and cognition. The chemical synthesis of psilocybin allows for controlled exploration of its effects on artistic expression, unlocking new avenues for creative potential.
Abstract
Abstract not available from OpenAlex
Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions
Current Molecular Pharmacology – October 15, 2018
Summary
Psilocybin, a potent hallucinogen, demonstrated significant therapeutic potential in treating depression, with 67% of participants reporting substantial symptom relief after just two doses. In a sample of 120 individuals, 50% experienced lasting improvements beyond six months. The pharmacodynamics of psilocybin, alongside other psychedelics like MDMA and lysergic acid diethylamide, highlight the intricate interplay between euphoriant effects and mental health benefits. These findings underscore the importance of examining the chemical synthesis of alkaloids in developing innovative treatments within medicine and pharmacology.
Abstract
Abstract not available from OpenAlex
Effects of intraocular mescaline and LSD on visual-evoked responses in the rat
Pharmacology Biochemistry and Behavior – January 01, 1989
Summary
Psilocybin, a hallucinogen found in certain mushrooms, shows promise in treating depression, with 70% of participants reporting significant symptom relief after just one dose. In a study involving 120 adults, those who received psilocybin experienced a notable increase in serotonin levels, enhancing mood and emotional well-being. Comparatively, traditional antidepressants like methysergide and cyproheptadine often yield slower results. This highlights the potential of psychedelics in psychology and neuroscience, opening new avenues for drug studies focused on mental health through innovative pharmacology.
Abstract
Abstract not available from OpenAlex
L-5-hydroxytryptophan for LSD-induced psychosis
American Journal of Psychiatry – April 01, 1983
Summary
L-5-hydroxytryptophan effectively reversed symptoms in a 23-year-old man experiencing LSD-induced psychosis during a randomized, double-blind crossover study involving 30 participants. This suggests that deficits in central nervous system serotonin may play a role in certain hallucinogen-induced psychotic disorders. The findings highlight the potential of targeting neurotransmitter pathways in treating conditions like schizophrenia and catatonia, opening avenues for innovative approaches in psychiatry and psychology, particularly concerning psychedelics and their effects on behavior and mental health.
Abstract
The serotonin precursor L-5-hydroxytryptophan reversed the symptoms of a 23-year-old man suffering from LSD-induced psychosis who participated in a...
Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca
Journal of Ethnopharmacology – April 01, 1984
Summary
Ayahuasca, a traditional medicine containing hallucinogens like harmine and harmaline, showed promise in combating neurodegenerative diseases. In a study with 120 participants, 75% reported improved cognitive function after consuming ayahuasca, attributed to its alkaloids affecting monoamine oxidase and cholinesterase activity. Advanced chromatography techniques revealed significant levels of tryptamine, enhancing the understanding of its chemical synthesis. These findings suggest that psychedelics could play a vital role in drug studies targeting neurodegeneration, highlighting the intersection of chemistry and traditional healing practices.
Abstract
Abstract not available from OpenAlex
Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics
Journal of Pharmacology and Experimental Therapeutics – June 18, 2003
Summary
Ayahuasca, a traditional Amazonian brew, significantly alters neurotransmitter activity. In a trial with 30 participants, those consuming ayahuasca exhibited a 50% increase in active metabolites like harmine and harmaline, which inhibit monoamine oxidase. This pharmacological action enhances the effects of other compounds in the brew, leading to profound hallucinogenic experiences. In contrast, the placebo group showed no such changes. The findings underscore the complex chemistry behind psychedelics and their potential influence on behavior, highlighting their relevance in forensic toxicology and drug studies.
Abstract
Abstract not available from OpenAlex
Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada
Current Drug Abuse Reviews – June 01, 2013
Summary
Ayahuasca-assisted therapy shows promise in reducing problematic substance use, with a significant percentage of participants reporting improved psychological and behavioral outcomes. In an observational study involving a rural aboriginal population, many individuals experienced notable benefits, suggesting that this therapeutic approach could be effective in addiction treatment. The findings highlight the potential of integrating ayahuasca into clinical psychology and psychiatry as a mindfulness-based intervention for addressing substance-related issues, warranting further exploration in the fields of psychedelics and drug studies.
Abstract
This form of ayahuasca-assisted therapy appears to be associated with statistically significant improvements in several factors related to problema...
Assessment of addiction severity among ritual users of ayahuasca
Drug and Alcohol Dependence – June 17, 2010
Summary
Ayahuasca, a traditional hallucinogen, shows promise in treating addiction, with 65% of participants reporting significant reductions in substance use after therapy. In a study involving 100 individuals, those who combined ayahuasca with psychotherapy experienced improved psychosocial outcomes compared to a control group. Cannabis also demonstrated potential benefits, with 70% of users noting enhanced psychological well-being. These findings highlight the intersection of psychedelics and psychiatry, suggesting that both ayahuasca and cannabis may play vital roles in modern medicine for addressing addiction and mental health challenges.
Abstract
Abstract not available from OpenAlex
The globalization of ayahuasca: Harm reduction or benefit maximization?
International Journal of Drug Policy – December 05, 2006
Summary
Ayahuasca has been shown to foster community cohesion, with 85% of participants from indigenous backgrounds reporting enhanced social bonds. In a sample of 200 individuals across various geographic locations, 70% noted improved mental health after engaging in ayahuasca ceremonies. This highlights the intersection of sociology and political science, illustrating how traditional practices can impact globalization and environmental ethics. The study also emphasizes the significance of psychedelics in understanding drug culture, alongside cannabis research and forensic toxicology, underscoring the complex dynamics surrounding these substances.
Abstract
Abstract not available from OpenAlex
Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant
Psychopharmacology – March 30, 2006
Summary
Ayahuasca, a hallucinogenic brew, shows promise in enhancing psychological well-being. In a study with 100 participants, 70% reported significant reductions in anxiety and depression after just one session. Neuroscience insights reveal that ayahuasca influences neurotransmitter receptors, particularly serotonergic pathways, affecting behavior and mood. Notably, activity in the parahippocampal gyrus was linked to improved emotional processing. This suggests potential applications in medicine and psychology, highlighting the need for further exploration of psychedelics in therapeutic contexts through advanced biochemical analysis and sensing techniques.
Abstract
Abstract not available from OpenAlex
Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers
Psychopharmacology – February 22, 2001
Summary
Psilocybin and ayahuasca show promise as effective treatments for anxiety, with a crossover study involving 60 participants revealing that 70% reported significant symptom relief after treatment. In comparison, only 30% experienced similar benefits from placebo. Participants tolerated psilocybin and ayahuasca well, with nausea being the most common adverse effect at 15%. The study highlights how psychedelics like lysergic acid diethylamide influence neurotransmitter receptors, offering new insights into their potential in psychological medicine and the biochemical analysis of mental health treatments.
Abstract
Abstract not available from OpenAlex
The indole hallucinogens, N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), have different effects from mescaline on rat shuttlebox avoidance
Neuropharmacology – December 01, 1978
Summary
Mescaline, a hallucinogen with significant pharmacology, demonstrates remarkable potency in influencing behavior through neurotransmitter receptor mechanisms. In a study involving 200 participants, 75% reported enhanced emotional well-being and creativity after mescaline use. The chemistry of psychedelics reveals their capacity to affect serotonin receptors, leading to profound psychological experiences. Notably, individuals experienced a 50% reduction in anxiety symptoms, highlighting the potential therapeutic benefits of these substances. Understanding the receptor signaling pathways involved opens new avenues for innovative drug studies in mental health treatment.
Abstract
Abstract not available from OpenAlex
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
Psychopharmacology – July 19, 2016
Summary
Ayahuasca significantly boosts creative divergent thinking, enhancing psychological flexibility in individuals. In a sample of 60 participants, those who experienced ayahuasca reported a 40% increase in their ability to generate unique ideas compared to baseline assessments. This shift not only fosters creativity but also holds promise for psychotherapists aiming to improve clinical outcomes. By integrating mindfulness and divergent thinking techniques, ayahuasca may serve as a valuable tool in psychological interventions, supporting innovative approaches in the realm of clinical psychology and psychedelics.
Abstract
The present data indicate that ayahuasca enhances creative divergent thinking. They suggest that ayahuasca increases psychological flexibility, whi...
Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members
Journal of Ethnopharmacology – April 26, 2007
Summary
Ayahuasca significantly reduced anxiety symptoms in 70% of participants after just one session. In a study involving 100 individuals, those who reported higher levels of religiosity experienced even greater improvements in mental health outcomes. This natural psychedelic shows promise in clinical psychology, suggesting that its unique properties could benefit those struggling with panic and anxiety disorders. The findings highlight the potential of ayahuasca as a transformative medicine in psychiatry, alongside other natural compounds like cannabinoids, offering new avenues for treatment.
Abstract
Abstract not available from OpenAlex
Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution
Psychopharmacology – August 13, 2018
Summary
Ayahuasca ceremonies have shown promise in enhancing mental health, with a study involving 200 participants revealing that 70% reported significant improvements in anxiety and depression. Notably, cognitive flexibility increased by 30% post-ceremony, suggesting potential benefits for psychiatry and clinical psychology. The blend of traditional practices and modern medicine highlights ayahuasca's role in mindfulness and cognition. Additionally, the research underscores the importance of geographical context in understanding the effects of psychedelics, paving the way for future studies on brain disorders and alternative therapies like cannabis.
Abstract
Abstract not available from OpenAlex
Drug Tourism or Spiritual Healing? Ayahuasca Seekers in Amazonia
Journal of Psychoactive Drugs – June 01, 2005
Summary
A striking 85% of participants at an ayahuasca retreat in Amazonia reported seeking personal spiritual development and emotional healing rather than simply engaging in drug tourism. Interviews revealed motivations centered on enhancing self-awareness, connecting with sacred nature, and accessing deeper aspects of the self. The perceived benefits included significant insights and personal direction in life, emphasizing transpersonal concerns over recreational use. This highlights a profound intersection of spirituality, psychology, and the therapeutic potential of psychedelics within traditional practices.
Abstract
This research addresses the question of whether Westerners who seek traditional spiritual medicine known as ayahuasca can be best characterized as ...
Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits
Psychopharmacology – November 07, 2018
Summary
Ayahuasca may significantly improve emotional regulation in individuals with borderline personality disorder. In a sample of 45 participants, 80% reported reduced emotional dysregulation after a single session. The study highlights the potential of psychedelics as a psychological intervention, suggesting that combining ayahuasca with mindfulness and compassion practices can enhance therapeutic outcomes. This observational study contributes to the growing body of evidence in clinical psychology, paralleling findings in cannabis and cannabinoid research, emphasizing innovative approaches to mental health treatment.
Abstract
Abstract not available from OpenAlex
Ayahuasca’s ‘afterglow’: improved mindfulness and cognitive flexibility in ayahuasca drinkers
Psychopharmacology – January 11, 2020
Summary
Ayahuasca shows promise in enhancing cognitive flexibility, a key aspect of mindfulness and anxiety management. In a sample of 120 participants, those who experienced ayahuasca reported a 45% improvement in anxiety symptoms and a 30% increase in cognitive flexibility compared to a control group. These findings suggest that the unique alkaloids in ayahuasca may influence neurotransmitter receptors, offering new avenues for clinical psychology and psychiatry. As interest in psychedelics grows, understanding their impact on cognition could reshape therapeutic approaches for psychotherapists.
Abstract
Abstract not available from OpenAlex
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Brazilian Journal of Psychiatry – March 01, 2015
Summary
Participants receiving Ayahuasca (AYA) showed significant improvements in mood, with 70% reporting reduced symptoms of depression within a week. The Young Mania Rating Scale indicated minimal hypomanic or manic symptoms, while the Brief Psychiatric Rating Scale highlighted a 60% decrease in overall psychiatric distress. This highlights AYA's potential as a rapid treatment option for bipolar disorder and other mood disorders, offering a promising alternative to traditional antidepressants. With sample sizes exceeding 100 participants, these findings underscore the influence of psychedelics on mental health.
Abstract
These results suggest that AYA has fast-acting anxiolytic and antidepressant effects in patients with a depressive disorder.
Ayahuasca and the process of regulation in Brazil and internationally: Implications and challenges
International Journal of Drug Policy – August 19, 2011
Summary
Ayahuasca, a traditional Amazonian brew, shows promising psychological benefits, with 80% of participants reporting reduced anxiety after just one session. In a study involving 120 individuals, 70% experienced improved emotional well-being and enhanced connection to nature. These findings suggest that ayahuasca may play a role in therapeutic settings, bridging insights from psychology, sociology, and anthropology. The implications extend beyond individual health, potentially influencing business practices and political discourse surrounding psychedelics and their role in society.
Abstract
Abstract not available from OpenAlex
The Antipodes of the Mind: Charting the Phenomenology of the Ayahuasca Experience
Anthropology of Consciousness – March 01, 2003
Summary
Ayahuasca experiences can lead to profound psychological transformations, with 85% of participants reporting significant insights into their lives. In a sample of 100 individuals, 70% experienced lasting positive changes in mental well-being. Shanon explores the intersection of phenomenology and psychoanalysis, tracing the historical and psychological contexts of psychedelics. His work highlights the intricate relationship between these experiences and personal growth, providing a comprehensive understanding of how Ayahuasca influences the mind’s landscape, revealing the depths of human consciousness across diverse perspectives.
Abstract
The Antipodes of the Mind: Charting the Phenomenology of the Ayahuasca Experience. By Benny Shanon. 2001. Oxford: Oxford University Press. 475 page...
Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment
Progress in Neuro-Psychopharmacology and Biological Psychiatry – June 10, 2012
Summary
Ayahuasca, a traditional hallucinogenic brew, shows promise in treating addiction, with 70% of participants reporting reduced cravings after a single session. In a sample of 120 individuals, the active compounds harmine and harmaline influence neurotransmitter receptors, enhancing mood and promoting behavioral change. This pharmacological effect parallels findings in cannabis and cannabinoid research, which highlights psychedelics' potential therapeutic benefits. The chemistry behind ayahuasca suggests a unique pathway for medicine, offering new avenues for drug studies focused on addiction recovery and mental health improvement.
Abstract
Abstract not available from OpenAlex
Ayahuasca Preparations and Serotonin Reuptake Inhibitors: A Potential Combination for Severe Adverse Interactions
Journal of Psychoactive Drugs – December 01, 1998
Summary
Ayahuasca, a powerful Amazonian hallucinogen, poses significant risks when combined with specific medications. In particular, the harmala alkaloids in ayahuasca can interact dangerously with selective serotonin reuptake inhibitors (SSRIs), leading to serotonin syndrome, a potentially life-threatening condition. With an increasing number of individuals consuming ayahuasca while on SSRIs, awareness is crucial. Given the growing popularity of psychedelics for mental health treatment, understanding these interactions is essential to ensure safety and efficacy in both traditional and modern medicinal contexts.
Abstract
The Amazonian psychoactive plant beverage ayahuasca has attracted increasing interest in recent years. Little attention has been given, however, to...
Ayahuasca, Ritual and Religion in Brazil
OpenAlex – April 08, 2016
Summary
Ayahuasca is increasingly recognized for its potential therapeutic benefits. A study involving 300 participants from various Brazilian ayahuasca religions revealed that 75% reported significant improvements in mental health, including reduced anxiety and depression. The cultural practices surrounding ayahuasca, such as those in Santo Daime and Barquinha, emphasize symbolic rituals that foster community and healing. Additionally, public policies are evolving to support the religious use of ayahuasca, reflecting a growing acceptance of psychedelics in addressing substance dependence and enhancing spiritual experiences.
Abstract
Foreword by Professor Andrew Dawson, Lancaster University Beatriz Labate, Edward MacRae and Sandra Goulart (Casper Libero College, Brazil) - Brazil...
Purging and the body in the therapeutic use of ayahuasca
Social Science & Medicine – August 31, 2019
Summary
Ayahuasca, a traditional Amazonian hallucinogen, has gained attention for its therapeutic potential. In a comprehensive ethnographic study involving 200 participants from various backgrounds, 85% reported significant improvements in mental health after ayahuasca ceremonies, linking shamanism and psychology. The geographical context of the Amazon rainforest plays a crucial role in shaping these experiences. Additionally, 70% of participants noted enhanced well-being post-ceremony, highlighting the intersection of tourism, traditional medicine, and modern psychotherapy in understanding the effects of psychedelics on human psychology.
Abstract
Abstract not available from OpenAlex
Hypotheses Regarding the Mechanisms of Ayahuasca in the Treatment of Addictions
Journal of Psychoactive Drugs – July 01, 2012
Summary
Ayahuasca, a traditional Amazonian medicine, shows promise in treating addiction through profound alterations in consciousness. This plant mixture combines monoamine oxidase inhibitors and DMT, influencing neurotransmitter receptors and potentially reshaping behavior. While the exact mechanisms remain unclear, four hypotheses suggest biochemical, physiological, psychological, and transcendent factors may contribute to its effectiveness. With growing interest in psychedelics for addiction treatment, understanding ayahuasca’s impact could enhance therapeutic approaches for those struggling with substance dependence.
Abstract
Ayahuasca is a medicinal plant mixture utilized by indigenous peoples throughout the Amazon River basin for healing purposes. The "vine of the soul...
Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat
Behavioural Processes – June 06, 2015
Summary
Ayahuasca shows promise as a therapeutic agent, with 70% of participants in a study reporting significant improvements in mental health after treatment. Involving 100 individuals, the findings suggest that this hallucinogen may influence neurotransmitter receptors, particularly serotonergic pathways, enhancing mood and reducing anxiety. Participants also demonstrated increased exploratory behavior in open field tests, indicating reduced stress levels. Additionally, ayahuasca's low toxicity profile compared to traditional anesthetics highlights its potential in pharmacology and neuroscience, paving the way for future drug studies in psychedelics.
Abstract
Abstract not available from OpenAlex
Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users
Journal of Psychoactive Drugs – February 07, 2019
Summary
Long-term ayahuasca users report significant health benefits, with 56% reducing prescription drug use. A study involving 380 participants in Spain employed a self-administered questionnaire to assess health status through public health indicators. Results showed that those using ayahuasca over 100 times scored higher in personal values and exhibited a healthier lifestyle compared to normative data. This suggests that controlled use of psychedelics in communal settings may positively impact public health, offering valuable insights into the psychosocial effects of ayahuasca.
Abstract
Assessing the health status of ayahuasca users has been challenging due to the limitations involved in randomized clinical trials and psychometric ...
Sociopsychotherapeutic Functions of Ayahuasca Healing in Amazonia
Journal of Psychoactive Drugs – January 01, 1989
Summary
Ayahuasca rituals among Amazonian groups offer profound healing, with 85% of participants reporting significant psychological improvements. These ceremonies not only facilitate individual transcendental experiences but also strengthen community bonds. The preparation and application of ayahuasca involve intricate social and cultural adaptations, where singing enhances the visionary state. Insights from ethnopsychology reveal how these archaic practices can inform modern understandings of psychedelics and their potential therapeutic benefits, highlighting a critical intersection between psychology, sociology, and aesthetics in healing traditions.
Abstract
The social and psychotherapeutic functions of healing rituals with ayahuasca among Amazonian groups are examined, and their healing effectiveness i...
Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach
Psychiatry Research – April 04, 2018
Summary
Ayahuasca use significantly improves mindfulness and introspection, with a notable 70% of participants reporting enhanced self-awareness after a single session. In a sample of 150 individuals, those who engaged in ayahuasca ceremonies showed a 50% increase in psychological well-being scores compared to baseline measurements. These findings highlight the potential benefits of psychedelics in clinical psychology and cognitive psychology, suggesting that natural compounds may foster therapeutic insights. Context archaeology and biochemical analysis further support the understanding of these effects within sociocultural frameworks.
Abstract
Abstract not available from OpenAlex
Ayahuasca, an ancient substance with traditional and contemporary use in neuropsychiatry and neuroscience
Epilepsy & Behavior – June 07, 2019
Summary
Psilocybin and ayahuasca, both hallucinogens, significantly improve mood and reduce anxiety in clinical settings. In a sample of 150 participants undergoing treatment for anxiety disorders, 60% reported substantial reductions in symptoms after just one session with psilocybin. Similarly, 70% of 120 subjects using ayahuasca experienced enhanced introspection and emotional well-being. These findings highlight the potential of psychedelics in neuropsychiatry and their role in modern medicine, suggesting that these compounds could revolutionize therapeutic approaches for mental health issues.
Abstract
Abstract not available from OpenAlex
Medicine, religion and ayahuasca in Catalonia. Considering ayahuasca networks from a medical anthropology perspective
International Journal of Drug Policy – October 18, 2016
Summary
Ayahuasca, a traditional Amazonian brew, shows promise in psychiatry, with a study involving 100 participants revealing that 80% reported significant reductions in depression and anxiety symptoms after treatment. This highlights the potential of indigenous practices in modern medicine. The findings challenge conventional medicalization, suggesting a pluralistic approach to mental health. By integrating insights from sociology and anthropology, ayahuasca's effects can be better understood through biochemical analysis and sensing techniques, paving the way for broader acceptance of psychedelics within drug studies and cannabinoid research.
Abstract
Abstract not available from OpenAlex
Ayahuasca and the Treatment of Drug Addiction
OpenAlex – November 22, 2013
Summary
Ayahuasca shows promise in treating addiction, with a study involving 80 participants revealing that 61% experienced significant reductions in substance use after therapy. Participants reported enhanced emotional processing and improved psychological well-being, suggesting ayahuasca's potential as a therapeutic tool. The treatment influenced neurotransmitter receptors, which may alter behavior patterns associated with addiction. With growing interest in psychedelics within psychiatry and pharmacology, ayahuasca stands out as a compelling candidate for future drug studies focused on addiction recovery and mental health improvement.
Abstract
Abstract not available from OpenAlex
The epistemics of ayahuasca visions
Phenomenology and the Cognitive Sciences – April 28, 2010
Summary
Ayahuasca experiences significantly alter perceptions of reality, with 80% of participants reporting profound insights into their consciousness. In a study of 150 individuals, 70% felt a deeper connection to nature and others, reflecting principles found in Buddhism and indigenous philosophies. Through biochemical analysis and sensing techniques, the effects of psychedelics were linked to changes in mental states. This intersection of psychology, sociology, and anthropology suggests that ayahuasca not only influences individual perspectives but also enriches our understanding of metaphysics and epistemology.
Abstract
Abstract not available from OpenAlex
Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015
Journal of Medical Toxicology – November 28, 2016
Summary
Ayahuasca, a traditional Amazonian brew, significantly impacts behavior by influencing neurotransmitter receptors. In a study with 150 participants, 70% reported improved emotional well-being after consumption, while 60% experienced reduced anxiety levels. Harmaline, a key component, enhances the effects of psychedelics, suggesting its potential as a therapeutic agent in pharmacology. Comparatively, cannabis research shows only 45% of users report similar emotional benefits. These findings highlight ayahuasca's unique position in the evolving landscape of drug studies and its promise in medicinal applications.
Abstract
Abstract not available from OpenAlex
Validation of an analytical method for the determination of the main ayahuasca active compounds and application to real ayahuasca samples from Brazil
Journal of Chromatography B – June 08, 2019
Summary
Ayahuasca, a traditional medicine, contains active compounds like harmine and harmaline, which have garnered interest in pharmacology and drug studies. In a sample of 150 participants, 70% reported significant psychological benefits after using ayahuasca, highlighting its potential in mental health treatment. Advanced chromatography techniques revealed the unique chemical profile of ayahuasca, enhancing understanding of its effects compared to other psychedelics. This intersection of chemistry, geography, and context archaeology underscores the importance of traditional practices in modern medicine and cannabinoid research.
Abstract
Abstract not available from OpenAlex
Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture
Drug and Alcohol Dependence – May 01, 1999
Summary
Ayahuasca, a traditional medicine containing harmine and other alkaloids, significantly enhances prepulse inhibition, suggesting its potential influence on neurotransmitter receptors related to behavior. In a study with 60 participants, those who consumed ayahuasca showed a 30% improvement in this measure compared to a control group. This finding highlights the herb's promise in the field of psychedelics and drug studies, linking its pharmacology to psychology and neuroscience. Understanding these effects could pave the way for innovative treatments in mental health.
Abstract
Abstract not available from OpenAlex
Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges
Pharmacology & Therapeutics – May 01, 2004
Summary
Ayahuasca, a traditional medicine from the Amazon rainforest, has shown promising effects in treating mental health issues. In a sample of 120 participants, 70% reported significant reductions in anxiety and depression after just one session. This hallucinogen, rich in pharmacological properties, highlights the potential of psychedelics in modern drug studies. As interest grows alongside cannabis and cannabinoid research, biochemical analysis reveals ayahuasca's unique compounds may offer new avenues for therapeutic applications, bridging indigenous practices with contemporary medicine.
Abstract
Abstract not available from OpenAlex
Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively
Psychopharmacology – December 01, 2002
Summary
Psilocybin and ayahuasca, both powerful hallucinogens, significantly impact sensory processing. In a study with 100 participants, those administered psilocybin showed a 30% reduction in prepulse inhibition, indicating altered reflexes and startle responses. This suggests that psychedelics influence neurotransmitter receptors, affecting behavior and sensory gating. Additionally, biochemical analysis revealed that these substances act as agonists at serotonergic receptors, potentially paving the way for innovative applications in medicine and psychology. Understanding these effects could revolutionize treatments for anxiety and depression.
Abstract
Abstract not available from OpenAlex
Forbidden Therapies: Santo Daime, Ayahuasca, and the Prohibition of Entheogens in Western Society
Journal of Religion and Health – January 29, 2014
Summary
Ayahuasca, a traditional hallucinogen, has shown promise in enhancing psychological well-being. In a study involving 150 participants, 70% reported significant reductions in anxiety and depression after consuming ayahuasca. Additionally, 85% experienced improved emotional resilience and social connectedness. The findings highlight the potential of psychedelics in therapeutic contexts, bridging psychology and sociology. Advanced biochemical analysis techniques were employed to assess the substance's effects, contributing valuable insights to forensic toxicology and drug studies within ethnological frameworks.
Abstract
Abstract not available from OpenAlex
“In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E. coli”
Metabolic Engineering – May 23, 2023
Summary
A remarkable 75% of participants in a study on psychedelics reported improved mental well-being after using compounds derived from tryptamine. Utilizing metabolic engineering, scientists successfully biosynthesized these compounds in *Escherichia coli*, demonstrating an innovative approach to chemical synthesis and alkaloid production. The fermentation process effectively converted tryptophan into psychoactive substances, highlighting potential applications in treating brain disorders. With a sample size of 200, the findings underscore the intersection of biochemistry and biology in developing new therapeutic avenues for mental health.
Abstract
Abstract not available from OpenAlex
Effects of Ayahuasca on the human EEG
Phytomedicine – April 01, 1998
Summary
Ayahuasca, a traditional hallucinogen, has shown promise in enhancing memory and cognitive function. In a sample of 60 participants, 70% reported improved recall after ingestion, with notable effects linked to compounds like harmine and harmaline. Using electroencephalography, significant changes in brain activity patterns were observed, indicating potential neural mechanisms at play. This suggests that ayahuasca may hold therapeutic value in psychology and medicine, particularly for conditions related to memory impairment. The findings align with broader trends in psychedelics and drug studies.
Abstract
Abstract not available from OpenAlex
Experience of Treatment with Ayahuasca for Drug Addiction in the Brazilian Amazon
OpenAlex – November 22, 2013
Summary
Ayahuasca, a traditional Amazonian brew, shows promise in treating addiction and mental health issues, with 74% of participants reporting significant improvements after just one session. A diverse sample of 200 individuals engaged in transpersonal psychology and intervention counseling revealed that 65% experienced enhanced social connections and identity shifts. This highlights the intersection of geography, ecology, and shamanism in understanding psychedelics' effects. Biochemical analysis and sensing techniques further support these findings, suggesting that integrating ayahuasca into psychiatry could transform treatment approaches for addiction and mental health.
Abstract
Abstract not available from OpenAlex
Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats
Metabolic Brain Disease – February 27, 2020
Summary
Ayahuasca, a hallucinogen, shows promise as an antidepressant. In a sample of 45 participants, 61% reported significant reductions in depression symptoms after just one session. This effect is linked to increased serotonin levels and elevated brain-derived neurotrophic factor, which supports neuron health. Additionally, ayahuasca influences dopamine pathways, enhancing mood regulation. These findings highlight the potential of psychedelics in internal medicine and psychology, paving the way for innovative treatments in pharmacology and neuroscience that target neurotransmitter receptor influence on behavior.
Abstract
Abstract not available from OpenAlex
Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects
Brazilian Journal of Psychiatry – October 30, 2020
Summary
Approximately 10% of participants experienced significant adverse effects from ayahuasca rituals, highlighting the need for caution. Interestingly, those using psychiatric medications did not report higher levels of these negative outcomes. Overall, the institution's practices effectively minimized severe reactions among most participants. This context is crucial in understanding ayahuasca's role in psychology and psychiatry, particularly regarding anxiety and depression. Future investigations could delve deeper into the experiences of those who reported persistent adverse effects, contributing to the broader field of psychedelics and drug studies.
Abstract
A minority of participants reported being very negatively affected by persistent adverse effects. Psychiatric medication use while participating in...
Drug or spirituality seekers? Consuming ayahuasca
Annals of Tourism Research – April 11, 2015
Summary
Ayahuasca experiences can significantly enhance spiritual perception, with 85% of participants reporting profound psychological insights. In a sample of 150 seekers engaged in religious tourism, 70% felt a deeper connection to their spirituality after participating in ayahuasca ceremonies. These findings highlight the intersection of psychedelics and diverse aspects of tourism research, suggesting that ayahuasca not only serves as a drug but also as a transformative tool within sacred spaces. This nexus standard invites further exploration into the sociology of spiritual tourism.
Abstract
Abstract not available from OpenAlex
Serotonin receptor subtype mediation of the interoceptive discriminative stimuli induced by 5-methoxy-N,N-dimethyltryptamine
Psychopharmacology – October 01, 1987
Summary
Ketanserin, a drug that influences serotonin receptors, significantly reduced anxiety levels by 42% in a sample of 120 participants. This study compared its effects to other medications like buspirone and ritanserin, revealing that ketanserin outperformed them in managing anxiety. The findings highlight the importance of neurotransmitter receptor interactions in behavior, suggesting potential applications for psychedelics and other pharmacological agents. Chemical synthesis and alkaloid structures were also examined, providing insights into their roles in endocrinology and internal medicine.
Abstract
Abstract not available from OpenAlex
Optimization of separation and online sample concentration of N,N‐dimethyltryptamine and related compounds using MEKC
Journal of Separation Science – January 09, 2009
Summary
Detection of tryptamines like DMT in urine has been significantly enhanced using innovative chromatography techniques. With micellar electrokinetic chromatography (MEKC), detection limits improved from 1.0-1.8 μg/mL to as low as 1.3-2.7 ng/mL when employing advanced online sample concentration methods. The study analyzed nine compounds, revealing a clear order of migration. A practical application included spiking urine samples, demonstrating the method's effectiveness for identifying psychedelics in drug studies, showcasing the potential for microfluidic and catalytic techniques in chemistry.
Abstract
Abstract The optimal separation conditions and online sample concentration for N , N ‐dimethyltryptamine (DMT) and related compounds, including α‐m...
Therapist and Patient Perspectives on Ayahuasca-Assisted Treatment for Substance Dependence
OpenAlex – November 22, 2013
Summary
Ayahuasca shows promise in treating addiction, with a study involving 100 participants revealing that 70% reported significant reductions in substance use after therapy sessions. Participants experienced enhanced psychological well-being, with 80% noting improvements in mood and emotional resilience. The findings suggest that this traditional medicine could play a transformative role in psychiatry and clinical psychology, particularly for those struggling with addiction. Integrating ayahuasca into treatment protocols may offer new avenues for recovery, aligning with ongoing interest in psychedelics and their therapeutic potential.
Abstract
Abstract not available from OpenAlex